We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04799054
Brief Title: A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

First Submitted : February 26, 2021
First Submitted that Met QC Criteria : March 11, 2021
First Posted : March 16, 2021

Last Update Submitted that Met QC Criteria : September 21, 2022
Last Update Posted : September 23, 2022